Trending...
- Dynamic Dachshund Dog Goes Global: Remember Point Launches a New Bilingual Children's Book
- Easwe D10, C20, and C30: Lightweight Folding Electric Wheelchairs Built for Easier Travel
- U.N. Committee Reiterates Forced Psychiatric Detention a Human Rights Violation; CCHR Calls on the U.S. to Implement Protections
PHILADELPHIA, Sept. 19, 2025 /PRNewswire/ -- Berger Montague, a national securities litigation law firm, advises shareholders of Hims & Hers Health Inc. ("Hims & Hers" or the "Company") (NYSE: HIMS) about an investigation into Hims & Hers' Board of Directors for potential breaches of fiduciary duties to the Company and its shareholders in connection with Novo Nordisk A/S's termination of its partnership with Hims & Hers.
Shareholders of HIMS & HERS may learn more about this investigation by contacting Berger Montague: Radha Raghavan at [email protected] or (332) 271-8908, or Andrew Abramowitz at [email protected] or (215) 875-3015 or by CLICKING HERE.
More on The PennZone
Berger Montague's investigation is focused on whether Hims & Hers' Board of Directors breached its fiduciary duties in the manner in which it oversaw the Company's partnership with Novo Nordisk, including in connection with Novo Nordisk's announcement in June 2025 that it was terminating its partnership with Hims & Hers on the basis that the Company had engaged in deceptive marketing practices with respect to unapproved compounded versions of semaglutide.
Berger Montague, with offices in Philadelphia, Minneapolis, Delaware, Washington, D.C., San Diego, San Francisco, Chicago, Malvern, PA, and Toronto has been a pioneer in securities class action litigation since its founding in 1970. Berger Montague has represented individual and institutional investors for over five decades and serves as lead counsel in courts throughout the United States.
More on The PennZone
Contacts:
Radha Raghavan, Associate
Berger Montague
(332) 271-8908
[email protected]
Andrew Abramowitz, Senior Counsel
Berger Montague
(215) 875-3015
[email protected]
SOURCE Berger Montague
Shareholders of HIMS & HERS may learn more about this investigation by contacting Berger Montague: Radha Raghavan at [email protected] or (332) 271-8908, or Andrew Abramowitz at [email protected] or (215) 875-3015 or by CLICKING HERE.
More on The PennZone
- Leeds Billboard Campaign Drives 188% Traffic Uplift as AI Enquiries Rise 266% for Loud! OOH
- Sister Files Lawsuit Against Georgia Funeral Home for Alleged Mishandling of Brother's Remains
- KeysCaribbean Resorts Offer Savings On Summer Vacations Now Through Aug. 31
- Crossroads4Hope Announces The Lipschutz Women's Fund
- AI, Drones, Defense & Explosive Growth: Why ZenaTech Is Emerging as One of the Most Compelling Technology Growth Stories (N A S D A Q: ZENA)
Berger Montague's investigation is focused on whether Hims & Hers' Board of Directors breached its fiduciary duties in the manner in which it oversaw the Company's partnership with Novo Nordisk, including in connection with Novo Nordisk's announcement in June 2025 that it was terminating its partnership with Hims & Hers on the basis that the Company had engaged in deceptive marketing practices with respect to unapproved compounded versions of semaglutide.
Berger Montague, with offices in Philadelphia, Minneapolis, Delaware, Washington, D.C., San Diego, San Francisco, Chicago, Malvern, PA, and Toronto has been a pioneer in securities class action litigation since its founding in 1970. Berger Montague has represented individual and institutional investors for over five decades and serves as lead counsel in courts throughout the United States.
More on The PennZone
- 91 Per Cent of Enterprises Will Increase AI Spending. Most Can't See the Cost — or the Risk!
- Harrisburg's newest restaurant, Eleve, sells out entire inventory during Grand Opening
- New ProEssentials v11: Native WinUI Charting Library, 100M Points in 15ms, Following Microsoft's Vision for True Native Swap-Chain Rendering
- New AI Customer Segmentation Guide Warns Marketers Not to Confuse Technical Precision With Business Value
- Salestrics Releases Version 2.0 to Unify CRM, Business Email, and Operations on a Single Customer Graph
Contacts:
Radha Raghavan, Associate
Berger Montague
(332) 271-8908
[email protected]
Andrew Abramowitz, Senior Counsel
Berger Montague
(215) 875-3015
[email protected]
SOURCE Berger Montague
Filed Under: Business
0 Comments
Latest on The PennZone
- Easwe D10, C20, and C30: Lightweight Folding Electric Wheelchairs Built for Easier Travel
- Cover Story about Matthew Cossolotto – Author of Harness Your PromisePower -- Published in July 2026 Enterprise World Magazine
- Philadelphia Community Invited to Unite for Praise-A-Thon Summer Concert Benefiting Cobbs Creek
- Lineus Medical Signs Partnership Agreement with DIMA MedTech to Support Expansion into Italy
- New Research: Deterministic Decompilation of Hermes Bytecode Back to Readable JavaScript
- The J. Wes Project Celebrates 11 Years of Love, Music & Inspiration
- Lionheart Holdings and KEO Energy Sign Letter of Intent for Proposed Business Combination
- MoMojo Records announces new album from Jad Tariq
- Marcus Christ Announces Singles: "The Hammer Goes Click" and "You Hate Me, I Hate You"
- Fatal FOMO May be Your Last Roll of the Dice
- Martin A. Sumichrast Joins Hawkeye Systems, Inc. as Chairman of the Board
- Allstream Energy Partners Returns as a Media Partner for the 2026 API Inspection & Mechanical Integrity Summit in San Antonio
- Community Partnership Brings Live Theater to 150+ Young People
- Best Rainbow Baby Charities That Support Bereaved Parents After Pregnancy Loss: A Complete Guide
- PokerStars & Ladbrokes veteran buys into Finnish news media Rahapelisanomat
- Former Judge Chris Oldner Honored as Best Lawyer by "D Magazine" for 6th Straight Year
- Missouri Hemp Businesses File Federal Lawsuit Challenging HB 2641
- Boston Industrial Solutions Launches New Citrine® SA1-370 Silicone Glue for Permanent Adhesion
- Northeast Airlines Launches New Asset Management Group
- AI Visibility Labs LLC - Dallas Texas - July 16 2026